Clinical Trial Update: Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia [Phase 1]

View source ↗

Summary

This entry reports a Phase 1 dose-escalation trial of mesenchymal stromal cells for medical xerostomia, including patients with graft-versus-host disease and Sj…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Sjögren Syndrome
• Xerostomia

Drugs mentioned

• Mesenchymal stromal cells

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Xerostomia, Graft-versus-host-disease | Phase 1 | Status: RECRUITING